Cargando…

Use of DPP-4 inhibitors in patients with COVID-19

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669493/
https://www.ncbi.nlm.nih.gov/pubmed/33201345
http://dx.doi.org/10.1007/s00592-020-01629-y
_version_ 1783610583425220608
author Kow, Chia Siang
Hasan, Syed Shahzad
author_facet Kow, Chia Siang
Hasan, Syed Shahzad
author_sort Kow, Chia Siang
collection PubMed
description
format Online
Article
Text
id pubmed-7669493
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-76694932020-11-18 Use of DPP-4 inhibitors in patients with COVID-19 Kow, Chia Siang Hasan, Syed Shahzad Acta Diabetol Letter to the Editor Springer Milan 2020-11-17 2021 /pmc/articles/PMC7669493/ /pubmed/33201345 http://dx.doi.org/10.1007/s00592-020-01629-y Text en © Springer-Verlag Italia S.r.l., part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Kow, Chia Siang
Hasan, Syed Shahzad
Use of DPP-4 inhibitors in patients with COVID-19
title Use of DPP-4 inhibitors in patients with COVID-19
title_full Use of DPP-4 inhibitors in patients with COVID-19
title_fullStr Use of DPP-4 inhibitors in patients with COVID-19
title_full_unstemmed Use of DPP-4 inhibitors in patients with COVID-19
title_short Use of DPP-4 inhibitors in patients with COVID-19
title_sort use of dpp-4 inhibitors in patients with covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669493/
https://www.ncbi.nlm.nih.gov/pubmed/33201345
http://dx.doi.org/10.1007/s00592-020-01629-y
work_keys_str_mv AT kowchiasiang useofdpp4inhibitorsinpatientswithcovid19
AT hasansyedshahzad useofdpp4inhibitorsinpatientswithcovid19